Interleukin (IL)-1, a pro-inflammatory cytokine, has been linked to enhanced cell proliferation, angiogenesis, adhesion, invasion, promotion, and metastasis in lung cancer through the expression of corresponding biomarker proteins. Here, IL1B is linked to lung carcinoma.